| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/JNS5.12066 |
| P698 | PubMed publication ID | 24862862 |
| P50 | author | Stephan Züchner | Q30500867 |
| P2093 | author name string | Justin Price | |
| Fan Zhang | |||
| Brad Bolon | |||
| Rong Wen | |||
| Jose P Silva | |||
| Adriana P Rebelo | |||
| Alleene V Strickland | |||
| P2860 | cites work | Mitochondrial fusion is required for mtDNA stability in skeletal muscle and tolerance of mtDNA mutations | Q33877979 |
| Role of mitofusin 2 in the renal stress response | Q34146617 | ||
| Developmentally regulated mitochondrial fusion mediated by a conserved, novel, predicted GTPase. | Q34433265 | ||
| Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations | Q34600251 | ||
| MFN2 mutations cause severe phenotypes in most patients with CMT2A. | Q34999364 | ||
| Acetylcholine enhancement in the nucleus accumbens prevents addictive behaviors of cocaine and morphine | Q35023045 | ||
| Mitochondrial dysfunction and Purkinje cell loss in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS) | Q35749838 | ||
| Complementation between mouse Mfn1 and Mfn2 protects mitochondrial fusion defects caused by CMT2A disease mutations | Q36117760 | ||
| Mitochondrial dynamics and peripheral neuropathy | Q36958205 | ||
| Expression of mitofusin 2(R94Q) in a transgenic mouse leads to Charcot-Marie-Tooth neuropathy type 2A. | Q43086039 | ||
| Hindlimb gait defects due to motor axon loss and reduced distal muscles in a transgenic mouse model of Charcot-Marie-Tooth type 2A. | Q43575927 | ||
| Adenine nucleotide translocase is involved in a mitochondrial coupling defect in MFN2-related Charcot-Marie-Tooth type 2A disease. | Q43735166 | ||
| Mitochondrial fusion protects against neurodegeneration in the cerebellum. | Q45931731 | ||
| The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system | Q46437005 | ||
| MFN2 mutation distribution and genotype/phenotype correlation in Charcot-Marie-Tooth type 2. | Q48530136 | ||
| Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2 | Q55670641 | ||
| Mitochondrial coupling defect in Charcot-Marie-Tooth type 2A disease | Q57898867 | ||
| Mitofusin 1 and mitofusin 2 are ubiquitinated in a PINK1/parkin-dependent manner upon induction of mitophagy | Q24300975 | ||
| Two Mitofusin Proteins, Mammalian Homologues of FZO, with Distinct Functions Are Both Required for Mitochondrial Fusion | Q28564175 | ||
| Mitofusin2 mutations disrupt axonal mitochondrial positioning and promote axon degeneration | Q28566372 | ||
| Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity | Q28572807 | ||
| Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development | Q28594513 | ||
| Close contacts with the endoplasmic reticulum as determinants of mitochondrial Ca2+ responses | Q29616076 | ||
| Mutations in the mitochondrial GTPase mitofusin 2 cause Charcot-Marie-Tooth neuropathy type 2A | Q29616547 | ||
| Disruption of fusion results in mitochondrial heterogeneity and dysfunction | Q29616566 | ||
| Mitofusin 2 tethers endoplasmic reticulum to mitochondria | Q29619861 | ||
| Mitofusin-2 maintains mitochondrial structure and contributes to stress-induced permeability transition in cardiac myocytes | Q30499251 | ||
| Charcot-Marie-Tooth neuropathy type 2A: novel mutations in the mitofusin 2 gene (MFN2). | Q33246172 | ||
| MFN2 point mutations occur in 3.4% of Charcot-Marie-Tooth families. An investigation of 232 Norwegian CMT families | Q33547163 | ||
| Unconventional transcriptional response to environmental enrichment in a mouse model of Rett syndrome | Q33633998 | ||
| Mitofusin 2 is necessary for transport of axonal mitochondria and interacts with the Miro/Milton complex | Q33779586 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 152-164 | |
| P577 | publication date | 2014-06-01 | |
| P1433 | published in | Journal of the Peripheral Nervous System | Q15764031 |
| P1476 | title | Characterization of the mitofusin 2 R94W mutation in a knock-in mouse model | |
| P478 | volume | 19 |
| Q38893801 | Common and Divergent Mechanisms in Developmental Neuronal Remodeling and Dying Back Neurodegeneration |
| Q91955757 | Disruption of genes associated with Charcot-Marie-Tooth type 2 lead to common behavioural, cellular and molecular defects in Caenorhabditis elegans |
| Q89743182 | Dominant mutations of the Notch ligand Jagged1 cause peripheral neuropathy |
| Q54985262 | Endoplasmic reticulum and mitochondria in diseases of motor and sensory neurons: a broken relationship? |
| Q26741616 | Function Over Form: Modeling Groups of Inherited Neurological Conditions in Zebrafish |
| Q33649447 | Human biallelic MFN2 mutations induce mitochondrial dysfunction, upper body adipose hyperplasia, and suppression of leptin expression |
| Q36210125 | Mice Hemizygous for a Pathogenic Mitofusin-2 Allele Exhibit Hind Limb/Foot Gait Deficits and Phenotypic Perturbations in Nerve and Muscle |
| Q50194442 | Mitochondrial deficits and abnormal mitochondrial retrograde axonal transport play a role in the pathogenesis of mutant Hsp27-induced Charcot Marie Tooth Disease |
| Q89295264 | Mitochondrial dynamics in adaptive and maladaptive cellular stress responses |
| Q98177463 | Mitofusin 2 Dysfunction and Disease in Mice and Men |
| Q55003621 | Mitofusin 2: from functions to disease. |
| Q89093203 | Mitofusin gain and loss of function drive pathogenesis in Drosophila models of CMT2A neuropathy |
| Q92435908 | Restoring mitofusin balance prevents axonal degeneration in a Charcot-Marie-Tooth type 2A model |
| Q47851457 | SCO2 mutations cause early-onset axonal Charcot-Marie-Tooth disease associated with cellular copper deficiency |
| Q90280870 | The tethering function of mitofusin2 controls osteoclast differentiation by modulating the Ca2+-NFATC1 axis |
Search more.